Cleared Traditional

K820251 - T4 DIAGNOSTIC KIT

K820251 is the FDA 510(k) clearance for T4 DIAGNOSTIC KIT by Diagnostic Reagents, Inc.. It is a Class 2 Chemistry device (product code CDP) cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K820251 · Diagnostic Reagents, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1982
Decision
96d
Days
Class 2
Risk

K820251 is an FDA 510(k) clearance for the T4 DIAGNOSTIC KIT. Classified as Radioimmunoassay, Total Triiodothyronine (product code CDP), Class II - Special Controls.

Submitted by Diagnostic Reagents, Inc. (Walker, US). The FDA issued a Cleared decision on May 5, 1982 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1710 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Reagents, Inc. devices

Submission Details

510(k) Number K820251 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 1982
Decision Date May 05, 1982
Days to Decision 96 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 88d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CDP Radioimmunoassay, Total Triiodothyronine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1710
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDP Radioimmunoassay, Total Triiodothyronine

All 91
Devices cleared under the same product code (CDP) and FDA review panel - the closest regulatory comparables to K820251.
AMERLEX FREE T-3 RIA KIT
K830980 · Amersham Corp. · May 1983
LEECO T3-RIA DIAGNOSTIC KIT
K830808 · Leeco Diagnostics, Inc. · Apr 1983
T3 DIAGNOSTIC KIT RIA
K821725 · Diagnostic Reagents, Inc. · Jun 1982
ENZYM-LINKED T3
K820763 · Icl Scientific · Apr 1982
QUANTICOAT NEONATAL 125 T4 RADIOIMMUNO
K812611 · Kallestad Laboratories, Inc. · Oct 1981
COAT-A-COUNT T3 RIA KIT
K812246 · Diagnostic Products Corp. · Aug 1981